tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

PODDInsulet Corporation

Health care · Medical Instruments · Nasdaq

Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. 10-K, Item 1

Employees
5,400
Headquarters
Acton, MA
CEO
Ashley McEvoy
Next results
around Feb 17, 2027
Compare with peers → Embed

Numbers in PODD's annual reports that a later 10-K reports differently for the same year and the same XBRL line item, fiscal years since 2020, changes of 0.5% or more. A change is a restatement (the company says the earlier number was wrong, in an 8-K item 4.02) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.

NumberPeriodFirst reportedLater reportedChangeWhy
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax · link
Fiscal year ending 2021-12-31 $1.10B
10-K filed 2022-02-24
$1.04B
10-K filed 2023-02-24
-5.3% Recast or revision
Receivables
AccountsReceivableNetCurrent · link
At 2021-12-31 $161.00M
10-K filed 2022-02-24
$135.20M
10-K filed 2023-02-24
-16.0% Recast or revision
Receivables
AccountsReceivableNetCurrent · link
At 2020-12-31 $83.80M
10-K filed 2021-02-24
$95.30M
10-K filed 2022-02-24
+13.7% Recast or revision

From SEC's XBRL company facts (6 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.

Work on PODD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/PODD/export.csv") into a cell.